Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$40.32 - $50.97 $487,872 - $616,737
-12,100 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$41.72 - $51.34 $216,944 - $266,968
-5,200 Reduced 30.06%
12,100 $563,000
Q3 2020

Nov 12, 2020

SELL
$37.02 - $51.28 $633,042 - $876,888
-17,100 Reduced 49.71%
17,300 $735,000
Q2 2020

Aug 13, 2020

BUY
$43.24 - $55.02 $38,916 - $49,518
900 Added 2.69%
34,400 $1.65 Million
Q1 2020

Jun 05, 2020

BUY
$34.37 - $60.07 $1.15 Million - $2.01 Million
33,500 New
33,500 $1.54 Million
Q1 2020

May 13, 2020

SELL
$34.37 - $60.07 $1.18 Million - $2.06 Million
-34,300 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$54.32 - $64.31 $16,296 - $19,293
300 Added 0.88%
34,300 $2.06 Million
Q3 2019

Nov 08, 2019

SELL
$53.25 - $59.98 $292,875 - $329,890
-5,500 Reduced 13.92%
34,000 $1.92 Million
Q2 2019

Aug 09, 2019

SELL
$46.61 - $58.45 $769,065 - $964,425
-16,500 Reduced 29.46%
39,500 $2.2 Million
Q1 2019

May 15, 2019

BUY
$38.66 - $51.82 $143,042 - $191,734
3,700 Added 7.07%
56,000 $2.83 Million
Q4 2018

Feb 12, 2019

BUY
$36.72 - $67.73 $282,744 - $521,521
7,700 Added 17.26%
52,300 $2.11 Million
Q3 2018

Nov 05, 2018

BUY
$66.65 - $83.86 $2.97 Million - $3.74 Million
44,600 New
44,600 $3.09 Million

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $8.46M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.